Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
KREBSBIO | NSE
-1.85
-2.00%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
19/09/2024
90.59
90.60
90.60
90.59
Krebs Biochemicals & Industries Limited manufactures and sells active pharmaceutical ingredients in India. The company develops biotech processes for application in medicine agriculture and industry fields. Its products include androstenedione lovastatin and simvastatin which are used for anti-cholesterol and steroid intermediate applications. The company is also developing various products including amlodipine cetirizine orlistat serratiopepetidase telmisartan and phenylephrine for anti-hypertension anti-histamine anti-obesity anti-inflammatory and cold and cough applications. In addition it offers contract manufacturing services for large pharmaceutical and multinational companies. The company was incorporated in 1991 and is headquartered in Hyderabad India.
View LessPositive Momentum
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Strong Revenue Growth (> 10%)
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
54.6%1 month
42.3%3 months
71.5%6 months
62.3%-
-
-
-1.62
1.09
-16.12
8.54
-
-77.92M
1.96B
23.50M
-
-29.89
-
21.80
-
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
21.60
Range1M
21.60
Range3M
52.22
Rel. volume
0.25
Price X volume
232.73K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Vaishali Pharma Limited | VAISHALI | Drug Manufacturers-Specialty & Generic | 192.25 | 2.06B | -1.98% | 333.23 | 31.49% |
Mangalam Drugs & Organics Limited | MANGALAM | Drug Manufacturers-Specialty & Generic | 127.32 | 2.02B | -6.02% | n/a | 72.53% |
Bal Pharma Limited | BALPHARMA | Drug Manufacturers-Specialty & Generic | 127.24 | 2.01B | -3.31% | 27.01 | 201.53% |
Bafna Pharmaceuticals Limited | BAFNAPH | Drug Manufacturers-Specialty & Generic | 79.14 | 1.89B | 658.33 | 30.17% | |
Aarey Drugs & Pharmaceuticals Limited | AAREYDRUGS | Drug Manufacturers-Specialty & Generic | 66.39 | 1.86B | -3.31% | 34.02 | 23.61% |
Lasa Supergenerics Limited | LASA | Drug Manufacturers-Specialty & Generic | 27.12 | 1.36B | -4.57% | n/a | 22.84% |
Ind-Swift Limited | INDSWFTLTD | Drug Manufacturers-Specialty & Generic | 23.81 | 1.29B | -1.37% | 3.23 | -146.78% |
Biofil Chemicals and Pharmaceuticals Limited | BIOFILCHEM | Drug Manufacturers-Specialty & Generic | 77.68 | 1.26B | -7.23% | 197.64 | 2.41% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Touchwood Entertainment Limited | TOUCHWOOD | Advertising Agencies | 166.42 | 1.85B | -3.27% | 49.20 | 4.88% |
Cubex Tubings Limited | CUBEXTUB | Copper | 93.74 | 1.34B | -3.01% | 34.07 | 21.78% |
Madhav Copper Limited | MCL | Copper | 36.42 | 1.02B | -1.33% | n/a | 32.70% |
Sagardeep Alloys Limited | SAGARDEEP | Copper | 28.12 | 483.23M | 88.75 | 43.14% | |
Heads UP Ventures Limited | HEADSUP | Apparel Retail | 14.67 | 331.86M | -1.48% | n/a | 0.00% |
Suumaya Industries Limited | SUULD | Apparel Retail | 4.93 | 296.65M | -2.38% | n/a | -118.72% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -16.12 | - | Cheaper |
Ent. to Revenue | 8.54 | - | Cheaper |
PE Ratio | - | 47.84 | - |
Price to Book | - | 6.55 | - |
Dividend Yield | - | - | - |
Std. Deviation (3M) | 71.46 | - | Riskier |
Debt to Equity | -1.62 | 0.34 | Cheaper |
Debt to Assets | 1.09 | 0.17 | Expensive |
Market Cap | 1.96B | - | Emerging |